Managing and Monitoring Infections and Neurological Toxicities in Patients Receiving Bispecific Therapies

Opinion
Video

Dr. Mohan discusses with Nurse Goff and Nurse Brigle the prevention and management of infections and neurological toxicities in patients receiving bispecific therapies, with a particular focus on the unique considerations of talquetamab targeting GPRC5D.

Video content above is prompted by the following:

  • How do you approach the prevention and management of infections in patients receiving bispecific therapies, particularly considering the unique target of talquetamab (GPRC5D)?
  • What are your protocols for monitoring and managing neurological toxicities in patients receiving bispecific therapies?
    • Are there any specific considerations for talquetamab?
Recent Videos
image of a woman in front of a blue background with a navy top
woman with a white top sitting in front of a green wall
a man wearing a suit and tie in front of a green screen with the ONN logo
Related Content